[KongchangAI]
Unverified90% confidenceDecision RuleTime unknown

优先选择病理科具备免疫组化和分子检测(ER/PR/HER2/Ki-67)能力的三级医院或专科医院,避免在只能做HE染色的基层机构穿刺后又需转院重做,重复穿刺增加肿瘤种植转移风险且延误治疗窗口

1
Sources
90%
Confidence
Long-term
Relevance
-
First Seen

Sources

Related Entities

Related Claims

Cite This Claim

Stable URI
https://kongchang.com/claim/197071
API
curl https://kongchang.com/api/v1/knowledge/claims/197071
MCP
get_claim(id=197071)